Search

everythinglearnresearchcommunity

for

Search:↓

Patients with alopecia areata in Saudi Arabia understand the condition's seriousness but still face significant psychological challenges.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

More severe hair loss in alopecia areata greatly impacts patients and caregivers.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

Significant, lasting hair regrowth is needed to improve how patients with Alopecia Areata feel about their condition.

Patients with Alopecia Areata are willing to trade life duration for better quality of life.

The Polish version of the Alopecia Areata Quality of Life Index is a reliable tool for assessing quality of life in Polish-speaking patients with alopecia areata.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Keratin 17 is crucial for early hair strength and cell survival.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Alopecia is a key indicator of thallium poisoning.

Frontal fibrosing alopecia is linked to four genetic areas, especially the HLA-B*07:02 allele.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Hair loss in men treated best with early medication or transplant, new treatments researched.

No treatment fully prevents hair loss from chemotherapy yet.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

Mice without the vitamin D receptor gene lose hair due to disrupted hair follicle cycles.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.